Subclinical cardiovascular disease and it's improvement after long‐term <scp>TNF</scp>‐α inhibitor therapy in severe psoriatic patients

Abstract

Patients with severe psoriasis exhibit signs of subclinical cardiovascular disease compared to control, and prolonged anti-TNF-α therapy has a potentially beneficial effect on these signs.